Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the ...

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...

Earnings call Dr. Lal PathLabs reported 10.7% YoY revenue growth and 19.3% PAT growth in Q3 FY25, despite no price increases. The company is executing a multi-pronged strategy of geographic expansion, ...

July 24 (Reuters) - Indian diagnostics firm Dr Lal PathLabs on Friday reported a rise in first-quarter profit, boosted ‌by sustained demand for its tests and preventive health ‌packages under the ...

Dr Lal PathLabs, one of the largest lab testing companies in India, left a huge cache of patient data on a public server for months, TechCrunch has learned. The lab testing giant, headquartered in New ...

Shares of Dr Lal Path Labs surged in morning trade on Monday after the diagnostics company reported better-than-expected June quarter results. The stock climbed as much as 7.55 percent during the ...

Algerian boxer Imane Khelif, who won gold at the Paris Olympics last summer, is once again at the centre of controversy over her biological sex. Khelif won gold at the Paris Games last summer - but it ...

Shares of Dr Lal PathLabs jumped nearly 8% on Monday to hit a new 52-week high after the diagnostics firm reported better-than-expected earnings for the first quarter of FY27, with multiple brokerages ...

Earnings call Dr. Lal PathLabs reported FY25 revenue of ₹2,461 crore, up 10.5% YoY, with PAT rising 35.9% to ₹492 crore (including a one-time tax benefit). Q4 margins expanded, but FY26 guidance ...

Consolidated net profit for the three months ended ‌June 30 ⁠rose to ⁠1.70 billion rupees ($17.62 million) from 1.32 billion rupees a year earlier. Consolidated net profit for the three months ended ...

Diagnostics firm Dr Lal PathLabs on Friday reported a rise in first-quarter profit, boosted by sustained demand for its tests and preventive health packages under the SwasthFit banner. The company’s ...